
Keywords: Festestrations; fenestrated and branched stent-grafts; thoracoabdominal aortic aneurysms; endovascular repair; fenestrations; branches; F-BEVAR; fenestrated and branched endovascular aortic repair; IDE; investigational device exemption; MAE; major adverse event; PMEG; ph